Esai and Biogen, Lequembi manufacturer, receive FDA approval for Alzheimer's drug. Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review. Source 8o.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,
Add Reply
Add Comment As A Guest
Close Topic Options